White House unveils MFN deals; Metsera saga ends; Q3 earnings updates; and morenews2025-11-08T11:00:57+00:00November 8th, 2025|Endpoints News|
Updated: Pfizer triumphs over Novo Nordisk with $10B bid for Metseranews2025-11-08T09:36:54+00:00November 8th, 2025|Endpoints News|
CMS unveils new Medicaid drug payment modelnews2025-11-07T20:56:28+00:00November 7th, 2025|Endpoints News|
FDA says it raised concerns about Biohaven’s ataxia study several times since it was proposednews2025-11-07T20:08:07+00:00November 7th, 2025|Endpoints News|
Gilead’s Trodelvy fails Phase 3 breast cancer studynews2025-11-07T20:02:05+00:00November 7th, 2025|Endpoints News|
#SITC25: Akeso, Summit’s PD-1xVEGF drug extends life in China lung cancer studynews2025-11-07T16:30:31+00:00November 7th, 2025|Endpoints News|
Sana suspends work on allogeneic CAR-T; Biokin eyes $387M raise in Hong Kongnews2025-11-07T15:27:39+00:00November 7th, 2025|Endpoints News|
ObesityWeek rode the momentum of the field’s most dramatic week in monthsnews2025-11-07T14:30:19+00:00November 7th, 2025|Endpoints News|
Lilly hires Denali executive to run neuroscience divisionnews2025-11-07T14:02:21+00:00November 7th, 2025|Endpoints News|
#AASLD25: Rivus’ MASH drug cuts liver fat, preserves muscle in mid-stage trialnews2025-11-07T13:00:37+00:00November 7th, 2025|Endpoints News|
